Raymond James Financial Services Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $364K | Buy |
25,585
+4,937
| +24% | +$70.2K | ﹤0.01% | 2835 |
|
|
2024
Q2 | $267K | Sell |
20,648
-5,473
| -21% | -$70.8K | ﹤0.01% | 2943 |
|
|
2024
Q1 | $363K | Sell |
26,121
-10,278
| -28% | -$143K | ﹤0.01% | 2727 |
|
|
2023
Q4 | $519K | Sell |
36,399
-9,229
| -20% | -$132K | ﹤0.01% | 2376 |
|
|
2023
Q3 | $706K | Sell |
45,628
-22,688
| -33% | -$351K | ﹤0.01% | 2112 |
|
|
2023
Q2 | $1.07M | Sell |
68,316
-1,281
| -2% | -$20.1K | ﹤0.01% | 1888 |
|
|
2023
Q1 | $1.15M | Sell |
69,597
-824
| -1% | -$13.6K | ﹤0.01% | 1819 |
|
|
2022
Q4 | $1.1M | Sell |
70,421
-87,325
| -55% | -$1.36M | ﹤0.01% | 1778 |
|
|
2022
Q3 | $2.05M | Sell |
157,746
-5,428
| -3% | -$70.4K | ﹤0.01% | 1409 |
|
|
2022
Q2 | $2.29M | Buy |
163,174
+7,712
| +5% | +$108K | 0.01% | 1364 |
|
|
2022
Q1 | $2.23M | Buy |
155,462
+8,624
| +6% | +$123K | ﹤0.01% | 1420 |
|
|
2021
Q4 | $2M | Sell |
146,838
-33,203
| -18% | -$452K | ﹤0.01% | 1534 |
|
|
2021
Q3 | $2.95M | Buy |
180,041
+7,913
| +5% | +$130K | 0.01% | 1260 |
|
|
2021
Q2 | $2.9M | Buy |
172,128
+25,074
| +17% | +$422K | 0.01% | 1262 |
|
|
2021
Q1 | $2.69M | Buy |
147,054
+74,856
| +104% | +$1.37M | 0.01% | 1228 |
|
|
2020
Q4 | $1.31M | Buy |
72,198
+19,315
| +37% | +$352K | ﹤0.01% | 1540 |
|
|
2020
Q3 | $943K | Buy |
52,883
+2,707
| +5% | +$48.3K | ﹤0.01% | 1585 |
|
|
2020
Q2 | $900K | Buy |
50,176
+23,093
| +85% | +$414K | ﹤0.01% | 1557 |
|
|
2020
Q1 | $411K | Buy |
27,083
+10,573
| +64% | +$160K | ﹤0.01% | 1660 |
|
|
2019
Q4 | $326K | Sell |
16,510
-1,716
| -9% | -$33.9K | ﹤0.01% | 2271 |
|
|
2019
Q3 | $313K | Sell |
18,226
-5,960
| -25% | -$102K | ﹤0.01% | 2220 |
|
|
2019
Q2 | $428K | Sell |
24,186
-1,718
| -7% | -$30.4K | ﹤0.01% | 2028 |
|
|
2019
Q1 | $528K | Buy |
+25,904
| New | +$528K | ﹤0.01% | 1868 |
|